Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 239

The DOI matches its OpenAlex record; 2 of the 2 references it cites were found in a registry or an index.

The Use of Antithyroid Drugs in Pregnancy and Lactation

Open access
Susan J. Mandel, David S. Cooper · 2001 · The Journal of Clinical Endocrinology & Metabolism

Abstract

The management of hyperthyroidism in the pregnant woman has been the topic of several recent reviews (1–6) and case series (7, 8). These papers have discussed maternal-fetal thyroid relationships, the epidemiology of maternal hyperthyroidism, causes of gestational thyrotoxicosis, the clinical and laboratory diagnosis of hyperthyroidism in pregnancy, therapy with ATDs, surgery, β adrenergic blocking drugs, and iodides, as well as the consequences of inadvertent radioiodine therapy and the implications of breast feeding. The purpose of this discussion is to provide an in depth examination of the use of ATDs in the pregnant hyperthyroid woman, rather than to present comprehensive guidelines for the treatment of hyperthyroidism during pregnancy furnished in other reviews (1–6). The subject continues to engender controversy because of the lack of prospective clinical trials and the relative rarity of the condition, occurring in only 1 of 1000–2000 pregnancies (7, 8). With more women receiving radioiodine before conception, the frequency may be even lower in the future. When one discusses the risks and benefits of ATD therapy in the management of the hyperthyroid pregnant women, the risks to the mother and fetus of untreated hyperthyroidism must also be considered. These risks appear to be directly related to the control or, more likely, the severity of the maternal hyperthyroidism. In a 1989 retrospective analysis of 181 hyperthyroid pregnant women (8), the subjects were separated into 3 groups: women who were euthyroid at presentation and remained that way (group 1, n = 34), women who were hyperthyroid at presentation but who were controlled during the pregnancy (group 2, n = 90), and women whose hyperthyroidism was not controlled (group 3, n = 57). The odds ratio (OR) for low birth weight (<2500 g) infants was not elevated in group 1 compared with normal control women. Group 2 women had an OR for low birth weight infants of 2.4 [95% confidence interval (CI) 1.4–4.1], and the OR was 9.2 (95% CI 5.5–16) in group 3 women. Similarly, prematurity was more common in groups 2 and 3 [OR in group 2, 2.8 (CI 0.33–23.5); OR in group 3, 16.5 (CI 2.1–130)] compared with group 1. Eclampsia was also more common in group 3 women (OR 4.7, CI 1.1–19.7). In this study there was no increase in the frequency of infants who were small for gestational age, although Mitsuda et al. (9) found a higher frequency of small-for-gestational-age infants in women who were thyrotoxic for more than 30 weeks during the pregnancy (26.7% vs. 7.7% among women who were euthyroid throughout pregnancy). Davis, et al. (7) found that 50% (4 of 8) of the infants born to untreated hyperthyroid women were stillborn vs. no stillbirths in the 36 treated euthyroid women. Also, 62% (5 of 8) of untreated hyperthyroid women had congestive heart failure vs. 3% (1 of 36) of treated euthyroid women. Interestingly, another study found that the altered hemodynamics seen in pregnant hyperthyroid women with congestive heart failure improved but did not normalize with restoration of a euthyroid state (10). This may be one explanation for the development of preeclampsia even in women whose hyperthyroidism is controlled during pregnancy (8). It is uncertain whether untreated Graves’ disease is associated with a higher frequency of congenital abnormalities. Mitsuda et al. (9) described congenital abnormalities in 6 of 230 (2.6%) infants born to mothers with Graves’ disease (3 with ventricular septal defect, 1 with cleft lip and palate, 1 with polydactyly, and 1 with diastasis recti abdominis). This rate was similar to the malformation rate in normal pregnancies, but it is not specified whether the mothers’ hyperthyroidism was controlled or not. In another report from Japan examining the relationship of fetal malformations to thyroid status in the first trimester (11), the rate of fetal malformations was 6% (3 of 50; imperforate anus, anencephaly, and cleft lip: 1 each) in untreated hyperthyroid women, 1.7% (2 of 117; ear lobe malformation and omphalocele) in treated hyperthyroid women, and 0% (0 of 126) in treated euthyroid women. In a report from the U.S. (12), the overall rate of fetal malformations was 3% (6 of 185): 3 of 99 (3%) of babies were born to women who were hyperthyroid during the first trimester (pulmonic stenosis, ventricular septal defect, patent ductus arteriosus: 1 each), and 3 of 96 (3%) born to women who were euthyroid in the first trimester(inguinal hernia in 2, hydrocephalus in 1). These data suggest that there may be a small increase in the rate of congenital anomalies in women with untreated or incompletely treated hyperthyroidism in the first trimester, but more information is clearly needed. ATD therapy is obviously indicated for hyperthyroidism when it is moderate or severe. Although there is no generally accepted definition of moderate or severe hyperthyroidism, it would be reasonable to treat women whose free T4 levels are more than 2.5 ng/dL i

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1210/jc.86.6.2354

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 239

Metadata

Authors
Mandel, S. J., & Cooper, D. S.
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
Oxford University Press
Published
2001-06-01
Volume
86
Issue
6
Pages
2354-2359
ISSN
0021-972X (ISSN-L)
OpenAlex
W1966487598
Cited by
239
References
2
FWCI
5.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Use of Antithyroid Drugs in Pregnancy and Lactation. https://app.cochat.ai/papers/10.1210/jc.86.6.2354
The paper
Mandel, S. J., & Cooper, D. S. (2001). The Use of Antithyroid Drugs in Pregnancy and Lactation. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.86.6.2354

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.